Top News Today: Bihar elections schedule, Nobel Prize in Medicine 2025 announced

Noor Mohmmed

13/Oct/2025

Bihar Assembly elections scheduled in two phases with results to be declared on November 14, 2025.
Nobel Prize in Medicine 2025 awarded to three scientists for groundbreaking work on immuno-regulatory T cells.
Additional major national and global developments impacting politics, science, and society are highlighted.

The day’s top headlines include key political and scientific developments shaping India and the world. In India, the Bihar Assembly elections are set to be conducted in two phases, with the counting of votes scheduled for November 14, 2025. Political analysts note that this election will be closely watched as it could influence the balance of power in the state and have wider implications for national politics. Major parties are strategizing intensely, with campaign activities ramping up across constituencies.

In global science news, the Nobel Prize in Medicine 2025 has been awarded to a trio of scientists for their pioneering work on immuno-regulatory T cells, a breakthrough that has transformed the understanding of immune system regulation. Their research is expected to pave the way for innovative therapies in autoimmune diseases, cancer, and transplant medicine, marking a milestone in biomedical science.

Additional highlights of the day include national updates on economy, infrastructure projects, social policies, and international affairs. Observers emphasize the interplay of politics, science, and policy as critical drivers of progress and societal impact.

This digest offers a comprehensive overview for readers seeking to stay informed about significant developments in India and around the world, from election schedules to scientific breakthroughs, enabling timely insights for decision-makers, professionals, and the general public.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey by Opening Free Account in Asset Plus.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Disclaimer

The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.

Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.

We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.

You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.

By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.

Services

Top News Today: Bihar elections schedule, Nobel Prize in Medicine 2025 announced

Related News

Disclaimer